Palo Alto, CA · Founded 2024 · Privately Held (backing)
Developer of precision enzymes and targeted drug delivery systems designed to advance the development of precision medicines. Ridge Bio is based in Palo Alto, CA and was founded in 2024. Its last reported valuation was $65 million in Sep 2025. It has raised $24.7 million.
Last reported valuation
$65.0M
Oct 2026
Priced at
—
Total raised
$24.7M
Last round
—
Cap table — not yet on record
Ridge Bio's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Ridge Bio with a free account
·Watch Ridge Bio: the Monday email on marks, rounds and moves
